New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a potential treatment for schizophrenia. The findings by researchers at the ...

In a cross-sectional study, researchers compared oral microbiota profiles and cognitive test scores in patients with schizophrenia and healthy controls. Within the schizophrenia group, lower microbial ...

Cognitive dysfunction is a defining characteristic impairing social functioning in schizophrenia (SZ). N-methyl-D-aspartate receptor (NMDAR) hypofunction may underlie these impairments. This study ...

An association between oral microbiota and cognitive performance in schizophrenia has been reported by researchers at Science Tokyo. By analyzing saliva samples and cognitive test scores from patients ...

Depersonalization, or a state of mind causing someone to feel disconnected from themselves, is a common symptom of ...

Nanoparticle-based drug delivery systems (DDS) containing peptides offer an innovative approach to effectively treat schizophrenia. Such DDSs hold significant potential to revolutionize therapeutic ...

No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review and network ...

“These impairments often persist even during periods of symptom remission and can have a profound impact on daily functioning and quality of life,” says Caroline Fenkel, a doctor of social work, a ...

Recent genomic research, considered in the wider context of knowledge from outside genomics, provides significant conceptual insights into the aetiology and pathogenesis of schizophrenia. The evidence ...

Cameras that have been installed in their homes by the CIA, voices that whisper vicious words, and demons that appear in their bedroom at night. These are the delusions and hallucinations of psychosis ...